| Tumor infiltrating B-cells are increased in prostate cancer tissue JR Woo, MA Liss, MT Muldong, K Palazzi, A Strasner, M Ammirante, ... Journal of translational medicine 12, 1-9, 2014 | 172 | 2014 |
| PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche E Godebu, M Muldong, A Strasner, CN Wu, SC Park, JR Woo, W Ma, ... Journal of translational medicine 12, 1-12, 2014 | 32 | 2014 |
| Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer ST Ryan, J Zhang, DN Burner, M Liss, E Pittman, M Muldong, A Shabaik, ... Journal of translational medicine 18, 1-11, 2020 | 28 | 2020 |
| Hypoxia-induced PIM kinase and laminin-activated integrin α6 mediate resistance to PI3K inhibitors in bone-metastatic CRPC RK Toth, JD Tran, MT Muldong, EA Nollet, VV Schulz, CC Jensen, ... American journal of clinical and experimental urology 7 (4), 297, 2019 | 25 | 2019 |
| Establishment and analysis of three-dimensional (3D) organoids derived from patient prostate cancer bone metastasis specimens and their xenografts S Lee, DN Burner, TR Mendoza, MT Muldong, C Arreola, CN Wu, ... JoVE (Journal of Visualized Experiments), e60367, 2020 | 22 | 2020 |
| A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand SC Lee, JSY Ma, MS Kim, E Laborda, SH Choi, EN Hampton, H Yun, ... Science Advances 7 (33), eabi8193, 2021 | 20 | 2021 |
| Novel dormancy mechanism of castration resistance in bone metastatic prostate cancer organoids S Lee, TR Mendoza, DN Burner, MT Muldong, CCN Wu, ... International journal of molecular sciences 23 (6), 3203, 2022 | 8 | 2022 |
| Specific bone region localization of osteolytic versus osteoblastic lesions in a patient-derived xenograft model of bone metastatic prostate cancer T Hirata, SC Park, MT Muldong, CN Wu, T Yamaguchi, A Strasner, ... Asian journal of urology 3 (4), 229-239, 2016 | 8 | 2016 |
| Prostate cancer progression relies on the mitotic kinase citron kinase C Rawat, S Ben-Salem, N Singh, G Chauhan, A Rabljenovic, V Vaghela, ... Cancer Research 83 (24), 4142-4160, 2023 | 3 | 2023 |
| MP70-20 B Cell Concentration In High Risk Prostate Cancer Specimens After Neoadjuvant Rituximab S Ryan, C Jamieson, A Shabaik, E Pittman, J Zhang, M Muldong, ... The Journal of Urology 199 (4S), e942-e942, 2018 | 2 | 2018 |
| PD07-04 pre-clinical studies for advancing cirmtuzumab-based anti-ror1 therapies in metastatic prostate cancer M Muldong, S Lee, T Mendoza, D Burner, C Wu, J Murtadha, E Koutouan, ... The Journal of Urology 207 (Supplement 5), e99, 2022 | 1 | 2022 |
| MP81-19 mechanisms of anti-androgen resistance in a 3D patient-derived organoid model of bone metastatic prostate cancer D Burner*, T Mendoza, M Muldong, S Lee, C Arreola, ... The Journal of Urology 201 (Supplement 4), e1179-e1180, 2019 | 1 | 2019 |
| MP61-14 MICROCT ANALYSIS REVEALED BONE REGION-SPECIFIC LOCALIZATION OF OSTEOLYTIC VERSUS OSTEOBLASTIC LESIONS IN PCSD1, A NEW PATIENT-DERIVED XENOGRAFT MODEL OF BONE METASTATIC … C Jamieson, T Hirata, SC Park, CN Wu, M Muldong, E Godebu, ... The Journal of Urology 193 (4S), e751-e751, 2015 | 1 | 2015 |
| Mp49-03 Tumor Infiltrating B-Cells Are Increased in Prostate Cancer Tissue J Woo, M Liss, M Muldong, A Strasner, N Varki, A Shabaik, S Howell, ... The Journal of Urology 191 (4S), e502-e503, 2014 | 1 | 2014 |
| Blockade of Wnt5A/ROR1 signaling as cancer stem cell targeting therapy for metastatic prostate cancer CAM Jamieson, J Murtadha, CS Oh, MT Muldong, N Etemadfard, ... Cancer Research 84 (6_Supplement), 5967-5967, 2024 | | 2024 |
| Abstract A015: Citron kinase is a novel driver of prostate cancer progression and controls alternative splicing associated with treatment-resistance C Rawat, N Singh, G Chauhan, A Rabljenovic, S Ben-Salem, V Vaghela, ... Cancer Research 83 (11_Supplement), A015-A015, 2023 | | 2023 |
| Pre-clinical studies to advance anti-ROR1 CAR-T cell therapy for metastatic prostate cancer CAM Jamieson, J Murtadha, CS Oh, M Muldong, E Koutouan, JO Kim, ... Cancer Research 83 (7_Supplement), 1789-1789, 2023 | | 2023 |
| PD04-10 PRE-CLINICAL STUDIES TO ADVANCE ZILOVERTAMAB-BASED ANTI-ROR1 DUAL SPECIFICITY CAR T-CELL THERAPY FOR METASTATIC PROSTATE CANCER. C Jamieson, J Murtadha, CS Oh, M Muldong, E Koutouan, JW Kim, ... The Journal of Urology 209 (Supplement 4), e146, 2023 | | 2023 |
| MP66-15 PATIENT-CENTRIC 3 DIMENSIONAL-BIOSYSTEMS FOR DEVELOPING PERSONALIZED IMMUNOTHERAPY FOR PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA S Lee, M Muldong, J Hsu, F Ghali, SG Kang, AK Kader, A Salmasi, ... Journal of Urology 206 (Supplement 3), e1135, 2021 | | 2021 |
| MP33-03 DORMANT CASTRATION-RESISTANT PROSTATE CANCER ORGANOIDS WITH HYBRID BASAL-LUMINAL CELLS AND LOSS OF SARS-COV-2 HOST FACTORS EMERGED UNDER ANDROGEN DEPRIVATION C Jamieson, S Lee, T Mendoza, D Burner, M Muldong, C Wu, C Arreola, ... The Journal of Urology 206 (Supplement 3), e607-e607, 2021 | | 2021 |
